Gene synthesis and cloning strategy

For a designed panel, cloning is a logistics problem more than a molecular biology problem. The sequences arrive as a list, they have to become plasmids that express, and every step where a human transcribes something is a step where a candidate quietly becomes a different candidate.

Synthesize or assemble

Synthetic genes are cheap enough that ordering the coding sequence outright is usually the right call for a panel. Assembly from fragments makes sense when candidates share large constant regions and differ only in the variable parts, which is common for antibody libraries, where one framework can be paired with many CDR sets.

Synthesis houses reject or flag sequences with extreme GC content, long repeats or strong secondary structure. Designed binders can hit all three, so build in time for a redesign of the nucleotide sequence, not of the protein.

Codon usage and what it actually buys

Codon optimization for the expression host is standard and usually helps. It is not magic. Rare codon clusters and strong mRNA structure near the start codon are the effects worth removing. Avoid optimizing away restriction sites you need, and keep the Kozak context and signal peptide junction clean for mammalian expression.

Vector choices that matter downstream

• Signal peptide. For secreted proteins in mammalian cells, the choice of signal peptide changes yield and can change the N-terminus you get. If the mature N-terminus matters, verify it by mass.
• Tag placement. A tag on the wrong terminus can block the paratope or interfere with folding. For VHHs a C-terminal tag is usual; for antigens, consider whether the tag should be cleavable.
• Cleavage sites. If you plan to remove a tag, put the protease site in from the start, and remember that cleavage leaves a scar.
• One backbone per format. Panels get compared. Comparisons are cleaner when every candidate sits in the same backbone with the same signal peptide and the same tag.

Assembly methods

Golden Gate and Gibson-style assembly both work well for panels. Golden Gate is better for repetitive, parallel builds with shared parts. Gibson is more forgiving when fragments are one-offs. Restriction and ligation still has a place for simple swaps. What matters more than the method is that the protocol is the same for every member of the panel, so failures are informative rather than mysterious.

Verification, which is not optional

Sequence-verify every construct over the full expression cassette, not just the insert. Errors turn up in promoters, signal peptides and at junctions. For a large panel, pooled sequencing of the plasmids is cheaper than Sanger reactions one by one and catches cross-contamination that Sanger will not.

Keep the verified plasmid map with the construct, and keep the construct identifier attached to every downstream well, plate and data file. Most of the confusion later in a campaign traces back to a lost mapping between a well and a construct.

Small things that cost days

• Two stop codons, so a readthrough does not add a tail.
• A unique identifier in the plasmid name that matches the design identifier exactly.
• Glycerol stocks made and recorded before the plasmid leaves the bench.
• Endotoxin-aware preps when the protein goes onto cells.